Your browser doesn't support javascript.
loading
Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
Gupta, Shashank; Cheung, Laurene; Pokkali, Supriya; Winglee, Kathryn; Guo, Haidan; Murphy, John R; Bishai, William R.
Afiliação
  • Gupta S; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Cheung L; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Pokkali S; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Winglee K; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Guo H; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Murphy JR; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Bishai WR; National Emerging Infectious Diseases Laboratories Institute, Boston University, Massachusetts.
J Infect Dis ; 215(12): 1883-1887, 2017 06 15.
Article em En | MEDLINE | ID: mdl-28863467

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Interleucina-2 / Linfócitos T Reguladores / Toxina Diftérica / Células Supressoras Mieloides / Imunoterapia / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Interleucina-2 / Linfócitos T Reguladores / Toxina Diftérica / Células Supressoras Mieloides / Imunoterapia / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2017 Tipo de documento: Article